CS logo
small CS logo
Beth Israel Medical Center - Singer Division

New York, New York, United States
Hospital in New York City, New York
281 1st Ave., New York, NY 10003
799 Beds

About Beth Israel Medical Center - Singer Division


Mount Sinai Beth Israel is a 799-bed teaching hospital in Manhattan. It is part of the Mount Sinai Health System, a nonprofit health system formed in September 2013 by the merger of Continuum Health Partners and Mount Sinai Medical Center, and an academic affiliate of the Icahn School of Medicine at Mount Sinai.
There are 799 beds in Beth Israel Medical Center - Singer Division.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Beth Israel Medical Center - Singer Division


During the past decade, Beth Israel Medical Center - Singer Division conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Medical Center - Singer Division" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Beth Israel Medical Center - Singer Division


According to Clinical.Site data, the most researched conditions in "Beth Israel Medical Center - Singer Division" are "Leukemia" (3 trials), "Neurofibromatosis Type 1" (1 trials) and "Precancerous Condition" (1 trials). Many other conditions were trialed in "Beth Israel Medical Center - Singer Division" in a lesser frequency.

Clinical Trials Intervention Types at Beth Israel Medical Center - Singer Division


Most popular intervention types in "Beth Israel Medical Center - Singer Division" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "daunorubicin hydrochloride" (2 trials), "dexamethasone" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Beth Israel Medical Center - Singer Division


The vast majority of trials in "Beth Israel Medical Center - Singer Division" are 4 trials for "All" genders.

Clinical Trials Status at Beth Israel Medical Center - Singer Division


Currently, there are NaN active trials in "Beth Israel Medical Center - Singer Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Beth Israel Medical Center - Singer Division, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Beth Israel Medical Center - Singer Division, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".